Unknown

Dataset Information

0

Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma.


ABSTRACT: The local microenvironment where tumors develop can shape cancer progression and therapeutic outcome. Emerging evidence demonstrate that the efficacy of immune-checkpoint blockade (ICB) is undermined by fibrotic tumor microenvironment (TME). The majority of hepatocellular carcinoma (HCC) develops in liver fibrosis, in which the stromal and immune components may form a barricade against immunotherapy. Here, we report that nanodelivery of a programmed death-ligand 1 (PD-L1) trap gene exerts superior efficacy in treating fibrosis-associated HCC when compared with the conventional monoclonal antibody (mAb). In two fibrosis-associated HCC models induced by carbon tetrachloride and a high-fat, high-carbohydrate diet, the PD-L1 trap induced significantly larger tumor regression than mAb with no evidence of toxicity. Mechanistic studies revealed that PD-L1 trap, but not mAb, consistently reduced the M2 macrophage proportion in the fibrotic liver microenvironment and promoted cytotoxic interferon gamma (IFNγ)+tumor necrosis factor α (TNF-α)+CD8+T cell infiltration to the tumor. Moreover, PD-L1 trap treatment was associated with decreased tumor-infiltrating polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) accumulation, resulting in an inflamed TME with a high cytotoxic CD8+T cell/PMN-MDSC ratio conductive to anti-tumor immune response. Single-cell RNA sequencing analysis of two clinical cohorts demonstrated preferential PD-L1 expression in M2 macrophages in the fibrotic liver, thus supporting the translational potential of nano-PD-L1 trap for fibrotic HCC treatment.

SUBMITTER: Liu X 

PROVIDER: S-EPMC9840184 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma.

Liu Xiaoyu X   Zhou Jingying J   Wu Haoran H   Chen Shufen S   Zhang Lingyun L   Tang Wenshu W   Duan Liang L   Wang Ying Y   McCabe Eleanor E   Hu Mengying M   Yu Zhuo Z   Liu Hanzhuang H   Choi Chung Hang Jonathan CHJ   Sung Joseph Jao-Yiu JJ   Huang Leaf L   Liu Rihe R   Cheng Alfred Sze-Lok AS  

Molecular therapy : the journal of the American Society of Gene Therapy 20220922 1


The local microenvironment where tumors develop can shape cancer progression and therapeutic outcome. Emerging evidence demonstrate that the efficacy of immune-checkpoint blockade (ICB) is undermined by fibrotic tumor microenvironment (TME). The majority of hepatocellular carcinoma (HCC) develops in liver fibrosis, in which the stromal and immune components may form a barricade against immunotherapy. Here, we report that nanodelivery of a programmed death-ligand 1 (PD-L1) trap gene exerts superi  ...[more]

Similar Datasets

| S-EPMC5873884 | biostudies-literature
| S-EPMC9909878 | biostudies-literature
| S-EPMC8193643 | biostudies-literature
| S-EPMC7458667 | biostudies-literature
| S-EPMC4322919 | biostudies-literature
| S-EPMC7542662 | biostudies-literature
| S-EPMC11011450 | biostudies-literature
| S-EPMC9192335 | biostudies-literature
| S-EPMC9012291 | biostudies-literature
| S-EPMC9862087 | biostudies-literature